GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Millennium Pharmacon International Tbk (ISX:SDPC) » Definitions » EPS (Basic)

PT Millennium Pharmacon International Tbk (ISX:SDPC) EPS (Basic) : Rp15.83 (TTM As of Mar. 2025)


View and export this data going back to 1990. Start your Free Trial

What is PT Millennium Pharmacon International Tbk EPS (Basic)?

PT Millennium Pharmacon International Tbk's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was Rp8.11. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was Rp15.83.

PT Millennium Pharmacon International Tbk's EPS (Diluted) for the three months ended in Mar. 2025 was Rp8.11. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was Rp15.83.

PT Millennium Pharmacon International Tbk's EPS without NRI for the three months ended in Mar. 2025 was Rp8.11. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 15.83.

During the past 12 months, PT Millennium Pharmacon International Tbk's average EPS without NRIGrowth Rate was -44.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 27.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 38.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 0.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, PT Millennium Pharmacon International Tbk's highest 3-Year average EPS without NRI Growth Rate was 110.40% per year. The lowest was -47.60% per year. And the median was 6.60% per year.


PT Millennium Pharmacon International Tbk EPS (Basic) Historical Data

The historical data trend for PT Millennium Pharmacon International Tbk's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Millennium Pharmacon International Tbk EPS (Basic) Chart

PT Millennium Pharmacon International Tbk Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.20 7.51 19.20 25.97 13.29

PT Millennium Pharmacon International Tbk Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.57 6.46 4.05 -2.79 8.11

PT Millennium Pharmacon International Tbk EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

PT Millennium Pharmacon International Tbk's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(16928.879-0)/1274.000
=13.29

PT Millennium Pharmacon International Tbk's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(10333.759-0)/1274.000
=8.11

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp15.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Millennium Pharmacon International Tbk  (ISX:SDPC) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


PT Millennium Pharmacon International Tbk EPS (Basic) Related Terms

Thank you for viewing the detailed overview of PT Millennium Pharmacon International Tbk's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Millennium Pharmacon International Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jl. Sultan Iskandar Muda No 18/Jl. Bungur No. 1, Crown Bungur Arteri Lantai 2-4, Kel. Kebayoran Lama Selatan, Kec. Kebayoran Lama, Selatan, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The operating segments of the group are Prescription medicine, Non-prescription medicine, and Medical devices, of which the majority of the revenue is derived from the Prescription Medicine segment.. The company's geographical segments are Java, Sumatera, Kalimantan, Sulawesi, and Bali.

PT Millennium Pharmacon International Tbk Headlines

No Headlines